MedPath

A Phase 2 Study of TRK-130 in Patients With Overactive Bladder

Phase 2
Conditions
Overactive bladder
Registration Number
JPRN-jRCT2080220843
Lead Sponsor
Toray Industries,Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients with a symptom of overactive bladder for more than 6 months

Exclusion Criteria

Patients with genius stress incontinence
Patients with clinically significant outflow obstruction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath